AI & ChatGPT searches , social queries for MYDECINE
Search references for MYDECINE. Phrases containing MYDECINE
See searches and references containing MYDECINE!
Search references for MYDECINE. Phrases containing MYDECINE
See searches and references containing MYDECINE!MYDECINE
Mydecine Innovations Group, or simply Mydecine, is an American and Canadian pharmaceutical company that is developing psychedelics and entactogens as medicines
Mydecine
Psychedelic drug
short duration of approximately 2 hours. The drug is being developed by Mydecine. As of December 2021, it is in preclinical research for psychiatric disorders
MYCO-004
Pharmaceutical compound
"Psilocybin Company Mydecine Is Down To $300k In Cash". Green Market Report. Retrieved 29 January 2025. Just last month Mydecine announced it has successfully
MYCO-006
Pharmaceutical compound
including Matthias Grill at MiHKAL in 2025. In addition, SDMA was patented by Mydecine as a shorter-acting MDMA alternative in 2023. Prodrugs of SDMA and/or related
SDMA_(drug)
Pharmaceutical compound
disorders. It is a short-acting MDMA analogue. MYCO-007 is being developed by Mydecine. As of February 2024, it is in preclinical research. The chemical structure
MYCO-007
Pharmaceutical compound
improving the safety profile of MDMA. The drug is under development by Mydecine. It was patented in July 2021 and received breakthrough therapy designation
MYCO-002
Psychedelic drug
for depressive disorders and anxiety disorders. It is being developed by Mydecine. The exact chemical structure of MYCO-005 does not yet seem to have been
MYCO-005
Chemical compound
by Matthew J. Baggott at Tactogen. The drug has also been patented by Mydecine and given the developmental code name MY400. Substituted benzothiophene
5-MAPBT
Mydecine Innovations Group - AdisInsight". adisinsight.springer.com. Ponieman, Natan. "Mydecine Unveils Four Psychedelic Drug Candidates - Mydecine Innovations
List of investigational hallucinogens and entactogens
List_of_investigational_hallucinogens_and_entactogens
Class of psychoactive drugs
149 (2–3): 181–92. doi:10.1016/j.forsciint.2004.06.016. PMID 15749360. Mydecine (5 January 2024). "Novel short-acting psychoactive compounds of the mdma
Substituted methylenedioxyphenethylamine
Substituted_methylenedioxyphenethylamine
Pharmaceutical compound
by Matthew J. Baggott at Tactogen. The drug has also been patented by Mydecine and given the developmental code name MY300. Substituted benzothiophene
6-MAPBT
(2010– ) Molecular Partners (2004– ) Mundipharma (1952– ) Mustang (2015– ) Mydecine (2020- ) Myrexis (1999– ) Myriad Genetics (1991– ) Nanjing Ange (2003–
List of pharmaceutical companies
List_of_pharmaceutical_companies
– MDMA (midomafetamine) MycoMedica Life Sciences – psilocybin (MLS101) Mydecine – psilocybin (MYCO-001/003), MYCO-006, MYCO-007, MYCO-002, MYCO-004, MYCO-005
List of psychedelic pharmaceutical companies
List_of_psychedelic_pharmaceutical_companies
List of pharmaceutical drugs under clinical development for treatment of depression
com. "NP 10679 - AdisInsight". adisinsight.springer.com. "Psilocybin - Mydecine Innovations Group - AdisInsight". adisinsight.springer.com. "PSYLO 5001
List of investigational antidepressants
List_of_investigational_antidepressants
Investigational substance-related disorder drugs
on MYCO-004 with Synapse". synapse.patsnap.com. Mydecine Innovations Group (7 April 2021). "Mydecine Announces Four Lead Novel Drug Candidates and Prepares
List of investigational substance-related disorder drugs
List_of_investigational_substance-related_disorder_drugs
Investigational PTSD drugs
undesirable after-effects of MDMA. Ponieman, Natan. "Mydecine Unveils Four Psychedelic Drug Candidates - Mydecine Innovations Gr (OTC:MYCOF)". Benzinga. "BETR
List of investigational post-traumatic stress disorder drugs
List_of_investigational_post-traumatic_stress_disorder_drugs
travel, tourism, insurance
MYDECINE
MYDECINE
MYDECINE
MYDECINE
MYDECINE
MYDECINE
MYDECINE
MYDECINE
MYDECINE
travel, tourism, insurance